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Abstract 
Background: A major bottleneck in drug delivery is the breakdown and degradation of the delivery system through 
the endosomal/lysosomal network of the host cell, hampering the correct delivery of the drug of interest. In nature, 
the bacterial pathogen Listeria monocytogenes has developed a strategy to secrete Listeriolysin O (LLO) toxin as a tool 
to escape the eukaryotic lysosomal system upon infection, allowing it to grow and proliferate unharmed inside the 
host cell.
Results: As a “proof of concept”, we present here the use of purified His‑LLO H311A mutant protein and its conjuga‑
tion on the surface of gold nanoparticles to promote the lysosomal escape of 40 nm‑sized nanoparticles in mouse 
embryonic fibroblasts. Surface immobilization of LLO was achieved after specific functionalization of the nanoparti‑
cles with nitrile acetic acid, enabling the specific binding of histidine‑tagged proteins.
Conclusions: Endosomal acidification leads to release of the LLO protein from the nanoparticle surface and its 
self‑assembly into a 300 Å pore that perforates the endosomal/lysosomal membrane, enabling the escape of 
nanoparticles.
Keywords: Nanoparticles, Lysosomal escape, Listeriolysin O toxin, Quantum dots, Drug delivery
© The Author(s) 2019. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creat iveco mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Drug delivery has become an important research field 
for the improvement of the safety and efficacy ratio in 
the application of established and new discovered drugs 
[1]. One important requisite is the robust vehiculation of 
the drug with nanocarriers, such as lipoplexes [2], poly-
plexes [2], liposomes [3], microspheres [4] and spheri-
cal or rod-shaped gold-nanoparticles [1, 5, 6]. The use 
of gold nanoparticles (Au-NPs) for biomedical purposes 
has considerably increased in the last few years owing 
to their good bio-compatibility and exceptional optical 
properties, allowing for the detection of small changes in 
the dielectric environment surrounding the particles [7, 
8]. Among said optical properties, nanostructured metals 
exhibit a surface plasmon resonance (SPR) signal (from 
500 nm to the near-infrared (NIR) [9]) emerging from the 
interaction between light and the conduction electrons, 
leading to a characteristic particle color depending on 
the size, shape, and composition of the NPs [10]. The NIR 
signal is of special interest for bio-medical applications 
as cellular tissue barely absorbs light in that wavelength 
range, thus providing an efficient spectral window for sig-
nal detection [11]. Therefore, NPs are not only vehicles 
but compounds of interest themselves for e.g. plasmonic 
photothermal therapy (PPTT), where laser-induced heat-
ing of Au-NPs induces the apoptosis or thermolysis of 
cancer cells [5]. To realize the full potential of Au-NPs 
in cellular applications, challenges regarding their con-
trolled uptake by cells, localization in the cellular cytosol, 
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or directed targeting of organelles must be overcome. The 
functionalization of the NP surface with engineered coat-
ings improves the hydrophilicity and biocompatibility of 
Au-NPs, as well as providing a means to attach unique 
targeting molecules to facilitate the cellular uptake of the 
carrier and allow the targeted delivery of the drug load 
[12]. This modification is crucial, as suitable surface func-
tionalization has a great impact on the success or failure 
of drug delivery. Au-NP internalization by eukaryotic 
cells occurs via the endosomal pathway, which starts with 
the invagination of the plasma membrane and eventu-
ally produces lysosomes for their degradation [13]. Such 
Au-NP degradation and/or rejection are major draw-
backs and important issues as drug synthesis is expensive 
and the therapy strategies developed so far are not very 
efficient [14]. Moreover, NPs have been recently shown 
to be expelled from the cells after an initial uptake [15]; 
thus, for therapeutic applications in PPTT, the residence 
time of the NPs inside the cell needs to be significantly 
increased.
Here, we present the surface functionalization of Au-
NPs with the pore-forming Listeria monocytogenes 
Listeriolysin O (LLO) toxin as a “proof of concept” to 
promote the lysosomal escape of Au-NPs inside mouse 
embryonic fibroblasts (MEFs) and reduce or even prevent 
their expulsion [16]. The LLO belongs to the cholesterol-
dependent cytolysin family (CDC) and is produced by the 
bacterial pathogen Listeria inside eukaryotic host cells 
during infection [17]. LLO facilitates the escape of the 
bacteria from the lysosomes of the host cell, thus guar-
anteeing the survival of the pathogen [18, 19]. LLO also 
plays a critical role in the protective immune response to 
L. monocytogenes. Increasing evidence arises that LLO is 
a multifunctional virulence factor that elicits a eukaryotic 
host response independent from the mechanical mem-
brane disruption including cell proliferation, the activa-
tion MAP kinases, mucus secretion in intestinal cells or 
the modulation of cytokine expression in macrophages. 
More details on these processes are discussed extensively 
by Vázquez-Boland et al. [20].
Cholesterol-dependent cytolysins are composed of four 
domains, each having a distinct role in the pore forma-
tion. Membrane binding and cholesterol recognition is 
mediated by the domain 4 [21, 22]. Once bound on the 
membrane surface, up to 50 monomers self-assemble 
into a pre-pore with a diameter of approximately 300 Å 
[23]. Within the CDCs, the ability of LLO toward pore 
formation is unique, being the most stable in the acidic 
pH environment, while neutral environment rapidly 
leads to aggregation of the protein [22, 24]. This allows 
maximum activity inside the late endosome or lys-
osomes, where pore formation in the lysosomal mem-
brane eventually destabilizes and breaks the lysosome 
liberating its contents [22, 25]. The conformational rear-
rangement of the LLO protein during pore forming pro-
cess is controlled by the presence of the acidic amino acid 
triad glutamine 247 (Glu247), asparagine 320 (Asp320), 
and glutamine 208 (Glu208) (Fig. 1a) [26]. At physiologi-
cal pH, this acidic triad is deprotonated, and the protein 
remains in compact conformation burying the hydropho-
bic amino acids inside the protein core. Upon protona-
tion due to acidification, the acidic triad is destabilized, 
and this promotes further changes in the conformation of 
the protein, which ultimately lead to pore formation [24]. 
Once released into the eukaryotic cytoplasm, Listeria 
proliferates and infects adjacent cells to initiate a new 
round of infection [19].
Results and discussion
In this work, we have used a histidine-tagged variant of 
LLO, where the histidine residue at position 311 is substi-
tuted by an alanine residue (LLO H311A mutant; Fig. 1a) 
[27]. Due to such change in the close vicinity of the acidic 
triad, the H311A mutation results in an acidity threshold 
for LLO pore maturation, whereby it only takes place at 
pH below < 6 [27]. In addition, an amino-terminal histi-
dine tag was employed not only for affinity purification of 
the protein, but also for surface functionalization of the 
Au-NPs. We purchased PEGylated Au-NPs  (InnovaCoat® 
GOLD Maleimide; SKU: 270-0005) and further function-
alized them with thiolated nitrilotriacetic acid (SH-NTA). 
This approach allows to specifically attach the histidine-
tagged LLO protein to the particle surface (Fig. 1b) and 
its release in an acidic environment. We tested the pore-
forming activity of the purified LLO protein in  vitro by 
the release of liposome-entrapped calcein. Calcein is a 
fluorescent dye with excitation and emission wavelengths 
of 495 and 515 nm, respectively. At concentrations above 
70  mM, the calcein fluorescence is attenuated by self-
quenching, being thus a suitable indicator of lipid vesicle 
leakage frequently used in pore forming toxins research 
[22]. We encapsulated calcein in small unilamellar vesi-
cles (SUVs) made of 1-palmitoyl-2-oleoyl-sn-glycero-
3-phosphocholine and cholesterol (POPC/Chol; 1:1; 
mol/mol) and monitored the change in the calcein fluo-
rescence signal in the presence of increasing amounts 
of purified His-LLO H311A or His-LLO wild type LLO. 
In  vitro, we observed stimulated pore-formation activ-
ity of LLO H311A at pH 5 and moderate activity at pH 
6–8 (Fig. 1c), while no strong pH-dependent pore forma-
tion was observed in the case of the LLO wild type pro-
tein (Additional file 1: Figure S1). Although the presence 
of cholesterol is required for pre-pore formation and 
acidification triggers the maturation in  vivo, additional 
factors, as the PEST domain (proline  (P), glutamic acid 
(E), serine (S), and threonine (T), present in the amino 
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terminal part of the protein, regulate the Listeria viru-
lence and the LLO pore-formation activity to selectively 
occur in late endosomes or lysosomes at low pH [28]. We 
also tested the integrity of POPC/Chol liposomes during 
LLO pore formation. We immobilized His-LLO wt on a 
10  mol% 1,2-dioleoyl-sn-glycero-3-[(N-(5-amino-1-car-
boxypentyl) iminodiacetic acid) succinyl (DOGS-NTA)-
doped POPC supported lipid bilayer (SLB) at pH 8. Next, 
giant unilamellar vesicles (GUVs) made of POPC/Chol 
(PC/Chol-GUVs) were added to the SLB. In the presence 
of LLO, we observed the attachment of sedimented PC/
Chol-GUVs to the SLB layer, as indicated by the reduced 
GUV mobility on the SLB surface. This local attachment 
occurs most likely through binding of PC/Chol-GUV to 
the cholesterol binding motif of the surface LLO protein 
(Additional file  1: Figure S2A), which was not observed 
in the absence of LLO (Additional file  1: Figure S2B), 
where the position of the sedimented PC/Chol-GUVs 
was found to change during confocal laser scanning 
microscopy (CLSM) imaging. To visualize the LLO pore 
formation, we added calcein to the buffer (pH 8). Calcein 
is membrane-impermeable and no calcein was observed 
inside the lumen of PC/Chol-GUVs until the buffer pH 
was acidified from 8 to 5.5. At pH 5.5, the calcein influx 
into the PC/Chol-GUVs is rather fast, being almost com-
plete in 5 min (Additional file 1: Figure S2A). Acidifica-
tion of the buffer triggers the surface release of the LLO 
protein and induces the LLO pore formation in the cho-
lesterol-containing PC/Chol-GUVs. The PC/Chol-GUVs 
did not collapse at the employed LLO concentration 
Fig. 1 a Crystal structure of LLO monomer (pdb:4CDB) highlighting the acidic triad and H311 amino acid residue; b scheme of the surface 
functionalization of Au‑NP; c In‑vitro calcein release experiments in the presence of increasing amounts of His‑LLO H311A at pH 5, 6, 7, and 8 at 
37 °C; d In‑vitro binding and release of His‑LLO H311A to/from Au‑NPs. The supernatant was separated from the Au‑NPs by centrifugation, showing 
the unbound excess of LLO H311A at pH 8 (lane 1), loosely bound His‑LLO H311A fraction washed with sodium phosphate buffer at pH 8 (lane 
2), and the specifically bound Ni‑NTA‑bound His‑LLO H311A fraction eluted with sodium phosphate buffer at pH 5 (lane 3). His‑LLO H311A was 
visualized by western blotting with monoclonal anti‑histidine antibody
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(1,9 nM final concentration) nor significant spontaneous 
disintegration of the sample was observed at incubation 
times shorter than 30 min (Additional file 1: Figure S2A). 
Higher concentrations of LLO (100–500  nM) destroy 
GUVs and GUV permeability cannot be attributed to dis-
crete LLO pore formation [25]. In the absence of LLO, 
no calcein influx was observed upon acidification (Addi-
tional file 1: Figure S2B).
For the present proof-of-concept, it is important that 
escape occurs in late endosomes or lysosomes at low pH; 
therefore, we evaluated the LLO surface release of LLO 
mutant H311A from LLO-bound Au-NPs. At neutral pH, 
the H311A-LLO mutant can associate into a membrane-
bound pre-pore [29], but will not penetrate and disrupt 
the membrane. LLO was attached via an amino-terminal 
histidine tag to the Ni-NTA group of the functionalized 
Au-NPs. The surface bound protein will only release 
from the surface upon acidification to low pH which 
will break the interaction of the Ni-NTA group and the 
histidine residues of the protein (Fig.  1b). The His-LLO 
H311A protein was incubated in excess with Au-NPs to 
saturate the protein content on the particle surface. The 
excess of unbound was removed by centrifugation to 
separate and collected the Au-NPs carrying LLO H311A 
from the unbound LLO H311A protein (Fig. 1d, lane 1). 
A consecutive wash with sodium phosphate buffer at pH 
8, followed by centrifugation, allowed the recovery of the 
particles (Fig. 1d, lane 2). To release the NTA-bound His-
LLO H311A from the particle surface, the washed Au-NP 
pellet was resuspended in sodium phosphate buffer at 
pH 5 and incubated for 10 min at RT. The acidic pH pro-
moted the release of the protein from the NTA-group of 
the Au-NPs, and His-LLO H311A was collected in the 
supernatant after Au-NP separation by centrifugation 
(Fig. 1d, lane 3).
To obtain some information on the particle surface 
charge, size and stability we measure the zeta poten-
tial and DLS profile of the functionalized Au-NPs in 
the absence and presence of LLO H311A. We obtain of 
− 13.1 ± 3.3 mV and − 2.12 ± 0.46 mV for the functional-
ized Au-NPs with and without LLO AuNP respectively. 
The presence of the Ni-NTA group on the Au-NP surface 
reduces the surface change below the threshold value 
(> − 30  mV and < 30  mV) expected for a stable Au-NPs 
suspension [30]. DLS experiments indicate that the bare 
Au-NPs have a hydrodynamic diameter of 35.5 ± 10.7 nm 
and Au-NPs carrying LLO H311A a hydrodynamic diam-
eter 67.9 ± 3.97  nm. Bare Au-NPs  and LLO-NPs poly-
dispersity index of 0.162 +/- 0.029 and 0.377 +/- 0.029 
respectively  and therefore we exclude excessive  particle 
aggregation during sample preparation. The Au-NPs with 
bound LLO H311A protein will be hereafter denoted as 
LLO-NPs.
The toxicity of LLO-NPs was then evaluated in MEF 
cultures using the resazurin (7-hydroxy-3H-phenoxazin-
3-one-10-oxide)-based  alamarBlue® cell viability assay, 
which reflects the redox state of the cell (fully reduced 
in live cells and fully oxidized in dead cells) [31]. Figure 2 
shows the cell viability results for MEFs in the presence 
of functionalized Au-NPs (black bars) and LLO-NPs 
(white bars). For both types of particles, a 30% loss of 
cell viability was observed within the first 2  h. Beyond 
that (up to 24 h), no further drop of the cell viability was 
observed. Therefore, we concluded that LLO-NPs are 
sufficiently biocompatible with MEF cultures and an easy 
and straightforward tool to test the LLO-mediated lyso-
somal escape of Au-NPs.
Lysosomal escape of the functionalized Au-NPs in liv-
ing MEF cultures was visualized and traced by CLSM; for 
this purpose, the Au-NPs were replaced by fluorescent 
quantum dots (Qdots). The employed Qdots are nanom-
eter-sized CdSe/ZnS semiconductor particles (Additional 
file  1: Figures  S3 and S4A) that absorb white light and, 
depending on their size and specific chemical composi-
tion, emit light at shorter (2–3 nm in diameter; blue and 
green) or longer wavelengths (5–6 nm diameter; orange 
or red) [32, 33]. We purchased Qdot™ 655 ITK™ Amino 
(PEG) (~ 8 × 15  nm in size, Thermofisher Scientific) 
for these experiments, which are coated with an amino 
polyethylene glycol (PEG-NH2) shell extending its size to 
a hydrodynamic diameter of ~ 20 nm [34] and exhibit a 
red fluorescence emission maximum at ~ 655  nm [35]. 
We functionalized these Qdots through the PEG-NH2 
layer, with a sulfosuccinimidyl 4-(N-maleimidomethyl) 
cyclohexane-1-carboxylate (sulfo-SMCC) cross-linker 
Fig. 2 MEF viability in hours after addition of Au‑NPs with (black bars) 
and without (white bars) LLO and Qdots with (dark gray) and without 
(light gray) LLO. Mean and error were calculated from of 12 replicas 
per timepoint
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and thiolated nitrilotriacetic acid (SH-NTA) (Addi-
tional file 1: Figure S3), as previously described [36], and 
first tested their capacity to bind and release His-LLO 
H311A. As seen for Au-NPs, Qdot-bound LLO H311A 
was released when the particles were resuspended in 
phosphate buffer at pH 5 (lane 3; Additional file  1: Fig-
ure S4B). If the amount of surface-precipitated LLO 
H311A is minimal, the Qdots retain about 65% less pro-
tein than the Au-NPs. The estimated Au-NP surface (AAu-
NPs = 5 × 104 nm2) is five times larger than that of Qdots 
(AQdots = 1.2 × 104 nm2) and the Au-NPs release 0.051 µM 
of LLO H311 per nM Au-NP per  nm2 in vitro in compar-
ison to 0.0175 µM LLO H311 per nM Qdot per  nm2. This 
difference may be related to the amount of conjugated 
PEG-NH2 on the commercially available particle in the 
first place (Fig. 1b). The cell viability of MEFs exposed to 
Qdots was like that observed for Au-NPs irrespective of 
the presence of LLO (Fig. 2). The Qdots conjugated with 
LLO H311A will be hereafter denoted as LLO-Qdots.
Next, MEFs were exposed to LLO-Qdots for analysis 
of the cellular uptake and eventual lysosomal escape. 
To distinguish the cytoplasmic or lysosomal localiza-
tion of the LLO-Qdots throughout the experiments, 
 LysoTracker® Green DND26 dye was employed in addi-
tion to Qdots to specifically visualize the cellular lyso-
somal system (Fig. 3a and b, top images, magenta). As a 
control, we incubated MEFs with functionalized Qdots 
without LLO H311A on their surface (bare Qdots, 
Fig. 3a). The Qdots in the endosome are seen in white 
color, while the Qdots that have escaped the endosomal 
system appear in yellow. After 2 h of exposure to LLO-
Qdots, we observed, albeit with very low intensity, the 
presence of yellow spots (Fig. 3b). This means that lys-
osomal escape of Qdots has occurred to some extent. 
Fig. 3 CLSM images of MEFs exposed to bare Qdots (a) and LLO‑Qdots (b). Lysosomes visualized with  LysoTracker® Green dye fluorescence at 
511 nm (green) and QDot fluorescence at 655 nm (red). Images are presented in false color [48], where the  LysoTracker® Green dye is shown in 
magenta and red Qdots are displayed in yellow when residing in the cytoplasm, or white inside the lysosomal system when colocalized with the 
magenta  LysoTracker® Green dye
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In general, the overall particle uptake is stronger for 
LLO-Qdots than for bare Qdots (45% vs 19%). This dif-
ference in uptake efficiency may be the result of the 
presence of a protein corona formed by non-specifically 
bound LLO protein on the particle surface [37]. When 
bare Qdots were incubated with 10 mg/mL of BSA pre-
vious to the administration to MEFs, the difference in 
uptake efficiency in comparison to LLO-Qdots was less 
pronounced (Additional file  1: Figure S5) [37]. At 3  h 
after LLO-Qdot exposure, the largest number of yel-
low spots (22%) was observed, which remained almost 
constant for 24  h (Fig.  3b). To avoid further losses in 
viability of the MEFs, no experiments were performed 
at higher initial concentrations of LLO-Qdots. These 
results demonstrate and validate the LLO toxin-medi-
ated endosomal escape of nanoparticles.
As the hydrodynamic diameter of the Qdots is 20 nm 
with a tendency to cluster into bigger aggregates inside 
cells (Fig. 3b) or in organic solution [38, 39], we imaged 
the MEFs by transmission electron microscopy (TEM) 
after 24 h of incubation with either bare Au-NPs (Fig. 4a), 
LLO-NPs (Fig. 4b), bare Qdots (Additional file 1: Figure 
S6C), and LLO-Qdots (Additional file  1: Figure S6D) to 
obtain a more detailed picture of the particle localiza-
tion. LLO-NPs and LLO-Qdots were found both inside 
endosomes/lysosomes and in the cytoplasm (Fig. 4b and 
Additional file  1: Figure S4D) whereas, in the absence 
of LLO, the bare particles were solely found inside the 
endosomes/lysosomes (Fig. 4a and Additional file 1: Fig-
ure S4C). We refer to endosome/lysosome as, without 
further treatment as immunogold labelling, the TEM 
images do not allow to distinguish between both types of 
Fig. 4 TEM images of MEFs incubated with bare Au‑NPs (a) and LLO H311A‑NPs (b). Bottom panels are zoomed areas of the top panel. N nucleus, E 
endosomes/lysosomes, M mitochondria
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vesicles. In general, as also observed by CLSM, the total 
amount of bare particles in the cell was smaller (Fig. 4a 
and Additional file  1: Figure S4C), as the presence of 
proteins on the particle surface promotes their uptake. 
Unexpectedly and irrespective of the presence of LLO, 
the Qdots were always found in the perinuclear area 
of the MEFs (Additional file  1: Figure S6). Even though 
Qdots were observed inside the lysosomes, we cannot 
exclude that, due to their small size, they may also enter 
the cell via other pathways not involving endosomes [40]. 
Perinuclear localization was not observed for 40  nm-
sized Au-NPs.
Drug-loaded liposomes decorated with the GALA pep-
tide [41] or arginine-rich cell-penetrating peptides (AR-
CPPs) [42–44] are the most common tools in the drug 
delivery field. These peptides induce a remodulation of 
the lipid bilayer membrane into multilamellar layers, 
leading to membrane fusion and pore formation. This 
type of peptides is very versatile, but the tailored design 
and synthesis of suitable CPPs can be hampered by their 
lack of target specificity, protease stability, and cytotox-
icity [45]. Further, the escape of lipid nanoparticles from 
acidifying late endosomes or lysosomes has been suc-
cessfully promoted by surface functionalization with the 
synthetic octa-arginine peptide (R8) [46, 47]. However, 
the detailed mechanism of how R8 induces endosomal 
escape may include the above mentioned CPP-induced 
liposome fusion, but in general remains elusive and 
not reliable enough for efficient drug delivery. We thus 
chose the LLO toxin as it enables better control of the 
target specificity as the presence of cholesterol in the 
host membrane allows its application to a wide range of 
eukaryotic cells [22, 48]. In addition, the use of a histi-
dine-tagged version provides very straightforward and 
cheap protein production in adequate amounts when 
compared to solid-phase tert-butyloxycarbony (Boc) or 
fluorenylmethyloxycarbonyl (Fmoc) peptide synthesis 
[39]. The surface conjugation via  Ni+-NTA allows the 
protein release at pH 5.3–4.5, at which the imidazole 
nitrogen atom of the histidine residue (pKa 6.0) becomes 
protonated that disrupts the coordination between 
the histidine and transition metal [49]. In the cell, this 
will only be the case when the Au-NPs reside in sorting 
endosomes, late endosomes and lysosomes with lumi-
nal pH values of 6.0, 5.5, and 4.9, respectively [50]. Up to 
30% cytotoxicity was observed during exposure of MEFs 
to NPs or Qdots. Due to the different size and composi-
tion of Au-NPs and Cd/Se Qdots, the strategy of using 
surface-conjugated LLO to promote escape from the lys-
osomes highlights the all-round potential of this tool and 
is therefore an important contribution to the advance-
ment of the delivery of large solid metal nanoparticles 
for therapeutic applications.
Conclusion
To our knowledge so far, we provide for the first-time evi-
dence of the lysosomal escape of 40 nm-size gold nano-
particles. These results allow the further development 
of the delivery strategy by changing either the type of 
Au-NP (size and geometry) for applications as photother-
mal therapy or to decorate the surface of the nanoparticle 
with signaling and targeting proteins able to direct the 
Au-NPs to G protein-coupled receptors (estrogen and 
progesterone receptors) of tumor cells or to specific orga-
nelles such as mitochondria or Golgi within cancer cells 
or cells suffering dysfunction related to these organelles.
Methods
Functionalization of nanoparticles
InnovaCoat® GOLD nanoparticles (10  nM; Antibody 
BCN, 270-0015) were incubated with 2 mM of thiolated 
nitrilotriacetic acid (NTA terminal-SAM formation rea-
gent, Sigma Aldrich 792438) according to manufacturer’s 
instruction. After conjugation of the NTA group to the 
Au-NP, the particles were centrifuged for 6 min at 9000g 
and pelleted particles were resuspended in 50 mM phos-
phate buffer pH supplemented with 1 mM of nickel chlo-
ride. Consequently, the AuNPs-NTA-(Ni) particles were 
centrifuged for 6 min at 9000g and pelleted particles were 
resuspended in 50 mM phosphate buffer pH and stored 
at 4 °C for further use. Quantum dots 655 (maximum of 
emission) coated with polyethylene glycol (QD655-PEG; 
Q21521MP; Invitrogen) were functionalized with nickel 
nitrilotriacetic acid (Ni-NTA) to allow conjugation of 
histidine-tagged proteins on their surface [36]. Briefly, 
8  µM of QD655-PEG dissolved in borate buffer 50  mM 
was incubated for 1 h at RT with 80 µM of the sulfosuc-
cinimidyl 4-(N-maleimidomethyl) cyclohexane-1-car-
boxylate (sulfo-SMCC) cross-linker dissolved in DMF. 
QD655::sulfo-SMCC was pelleted three times by cen-
trifugation for 15 min at 7437g in a Beckman microfuge 
(all centrifugations were performed under the same 
conditions) to remove non-reacted sulfo-SMCC from 
the mixture and resuspended in 50  mM PBS. In a sec-
ond reaction, 800  µM of thiolated nitrilotriacetic acid 
(NTA terminal-SAM formation reagent, Sigma Aldrich 
792438) dissolved in DMSO was added to the QD655-
PEG::sulfoSMCC mixture and incubated for 2  h at RT 
under continuous stirring. QD655-PEG::sulfoSMCC::S-
NTA (QD655-NTA) was pelleted three times by centrifu-
gation to remove non-reacted SH-NTA from the mixture 
and then resuspended in 50  mM PBS. Finally, QD655-
NTA was incubated with 800  µM of nickel chloride for 
1  h at RT under continuous stirring to coordinate the 
NTA group for efficient binding to the histidine residue 
of the protein of interest. QD655-Ni-NTA was pelleted 
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three times by centrifugation to remove the non-reacted 
nickel from the mixture and resuspended in 50 mM PBS.
LLO binding to functionalized nanoparticles
The purified His-LLO H311A protein was mixed at dif-
ferent mol/mol ratios with functionalized 1  nM Qdots 
(1000:1) and 0.2  nM Au-NPs (12,000:1) and tested for 
protein binding and release. First, Qdots or Au-NPs were 
incubated with His-LLO for 10  min in 50  mM sodium 
phosphate buffer pH 7.4 and then centrifuged for 15 min 
at 7500g (Beckman Microfuge 18 Centrifuge) to sepa-
rate LLO-bound nanoparticles from unbound LLO. The 
supernatant was collected for Western blot analysis and 
the pellets were resuspended in upon resuspension in 
50  mM sodium phosphate buffer pH 7.4. To wash the 
LLO-bound NPs, upon resuspension in 50  mM sodium 
phosphate buffer pH 7.4, the samples were centrifuged 
for 15 min at 7500g (Beckman Microfuge 18 Centrifuge) 
and the obtained pellets were separated from the super-
natant and resuspended in fresh 50  mM sodium phos-
phate buffer pH 7.4. This was repeated three times before 
the pellets were finally resuspended in 50  mM sodium 
phosphate buffer pH 5.5 to release the LLO protein from 
the particle surface. The sample was centrifuged at 7500g 
and the pellet was separated from the supernatant. To 
visualize the amount of LLO bound to the NPs, Western 
blot analysis of the supernatants was performed for the 
initial binding, final washing, and release steps.
Confocal laser scanning microscopy
Confocal laser scanning microscopy (CLSM) images 
were taken at 1, 2, 3, 5, and 24 h to monitor the evolu-
tion of the lysosomal escape of Qdots mediated by His-
LLO. MEFs were seeded at 1 × 104 cells per  cm2 in a 
four-chamber Lab-Tek® slide (Thermofisher) and incu-
bated in complete DMEM for 24 h at 37  °C. To image 
the lysosomal escape of LLO-conjugated Qdots, MEFs 
were supplemented with LLO H311A-Qdots or non-
conjugated bare Qdots at a final concentration of 1 nM 
together with 50  nM of  LysoTracker® Green DND-26 
(Invitrogen) to simultaneously visualize the lysosomes 
and incubated up to 24 h. The  LysoTracker® Green flu-
orescence was excited at 488 nm and the QDot655 fluo-
rescence at 561  nm. The Lab-Tek® slide was mounted 
on the temperature-controlled (37  °C) stage of an 
inverted Nikon Ti-E microscope equipped with a Nikon 
point scanning confocal microscope module C2, Nikon 
Plan Apo 100 × NA 1.45 oil immersion objective and 
two lasers (488 nm and 561 nm; Sapphire laser). Quan-
tification was performed by counting the red (Qdots), 
green  (LysoTracker® Green), and yellow colored sig-
nal dots (colocalization). Red and green colors were 
changed to magenta and yellow producing a white 
signal to indicate colocalization [51]. The images were 
captured with the Nikon NIS-Elements software and 
further processed with ImageJ [52].
Transmission electron microscopy
For TEM imaging, MEFs were seeded at 1 × 104 cells per 
 cm2 in a four-chamber Lab-Tek® slide (Thermofisher) and 
incubated in complete DMEM for 24 h at 37 °C. To image 
the endosomal/lysosomal escape of His-LLO H311A-
coated Au-NPs and His-LLO H311A-coated Qdots, 
MEFs were exposed for 24 h to His-LLO H311A-AuNPs, 
LLO H311A-Qdots, bare Au-NPs, or bare Qdots at a 
final concentration of 0.2 nM (Au-NPs) or 1 nM (Qdots). 
The cells were collected by centrifugation for 15  min at 
209g (Beckman F301.5 Rotor), washed and fixed with 2% 
glutaraldehyde in PBS buffer, and then stained with 1% 
osmium tetroxide and 1.5% potassium cyanoferrate. The 
samples were gradually dehydrated with acetone, embed-
ded in Epon, and cut by ultramicrotomy (60 nm sections) 
for observation. TEM images were taken with a JEOL 
JEM-1010 transmission electron microscope operating at 
an acceleration voltage of 80  kV (CNME, UCM, Spain). 
The captured images were further processed with the 
ImageJ software package [47].
Supplementary information
Supplementary information accompanies this paper at https ://doi.
org/10.1186/s1295 1‑019‑0543‑6.
Additional file 1. Supplemental Experimental Section, Supplemental 
Figures S1 to S6 and Supplemental References.
Abbreviations
Au‑NP: gold nanoparticle; Chol: cholesterol; CLSM: confocal laser scanning 
microscopy; CDC: cholesterol‑dependent cytolysins; DOGS‑NTA: 1,2‑dioleoyl‑
sn‑glycero‑3‑[(N‑(5‑amino‑1‑carboxypentyl) iminodiacetic acid succinyl; 
DMEM: Dulbecco’s Modified Eagle Medium; DMF: dimethylformamide; GUVs: 
giant unilamellar vesicles; His: histidine; LLO: Listeriolysin O toxin; MEF: mouse 
embryonic fibroblasts; Ni‑NTA: nickel‑nitrilotriacetic acid; NP: nanoparticle; 
PEG: polyethylene glycol; POPC: 1‑palmitoyl‑2‑oleoyl‑sn‑glycero‑3‑phos‑
phocholine; PBS: phosphate buffer saline; Qdots: quantum dots; sulfo‑SMCC: 
sulfosuccinimidyl 4‑(N‑maleimidomethyl) cyclohexane‑1‑carboxylate; SLB: 
supported lipid bilayer; SH‑NTA: thiolated nitrilotriacetic acid; TEM: transmis‑
sion electron microscopy.
Acknowledgements
MMÚ thanks the Sara Borrell program funded by financed by the Spanish 
Ministry of Health (Grant No‑CD15/00190).
Authors’ contributions
IL‑M, PN and AG‑M conceived and designed the experiments. IPG‑A, VM‑G, 
VA‑V, MM‑U and PN performed the experiments. MK and GA provided materi‑
als. MK, GA, PN and IL‑M analyzed the data. PN, and IL‑M drafted and wrote the 
manuscript. All authors read and approved the final manuscript.
Funding
This work was financial supported by the European Research Council (ERC‑
StG‑338133, mitochon) to ILM, and grants financed from the Spanish MICINN 
Page 9 of 10Plaza‑GA et al. J Nanobiotechnol          (2019) 17:108 
(RTI2018‑095844‑B‑I00), the Madrid Regional Government (S2018/NMT‑4389) 
and the Complutense University of Madrid (PR75/18) to AGM.
Availability of data and materials
All data generated or analyzed during this study are included in this published 
article.
Ethics approval and consent to participate
Not applicable.
Consent for publication
All authors have provided consent for the manuscript to be published.
Competing interests
The authors declare that they have no competing interests.
Author details
1 Departamento de Química Física, Universidad Complutense de Madrid, 
Madrid, Spain. 2 Instituto de Investigación Hospital “12 de Octubre” (i+12), 
Madrid, Spain. 3 Department of Molecular Biology and Nanobiotechnology, 
National Institute of Chemistry, Ljubljana, Slovenia. 
Received: 25 June 2019   Accepted: 3 October 2019
References
 1. Tiwari G, Tiwari R, Sriwastawa B, Bhati L, Pandey S, Pandey P, Bannerjee 
SK. Drug delivery systems: an updated review. Int J Pharm Investig. 
2012;2:2–11.
 2. Shende P, Ture N, Gaud RS, Trotta F. Lipid‑ and polymer‑based 
plexes as therapeutic carriers for bioactive molecules. Int J Pharm. 
2019;558:250–60.
 3. Abu Lila AS, Ishida T. Liposomal delivery systems: design optimization and 
current applications. Biol Pharm Bull. 2017;40:1–10.
 4. Ghosh Dastidar D, Saha S, Chowdhury M. Porous microspheres: synthesis, 
characterisation and applications in pharmaceutical & medical fields. Int J 
Pharm. 2018;548:34–48.
 5. Ahijado‑Guzman R, Gonzalez‑Rubio G, Izquierdo JG, Banares L, Lopez‑
Montero I, Calzado‑Martin A, Calleja M, Tardajos G, Guerrero‑Martinez 
A. Intracellular pH‑induced tip‑to‑tip assembly of gold nanorods for 
enhanced plasmonic photothermal therapy. ACS Omega. 2016;1:388–95.
 6. Brunetaud JM, Mordon S, Maunoury V, Beacco C. Non‑Pdt uses of lasers in 
oncology. Lasers Med Sci. 1995;10:3–8.
 7. Murphy CJ, Sau TK, Gole AM, Orendorff CJ, Gao J, Gou L, Hunyadi SE, Li T. 
Anisotropic metal nanoparticles: synthesis, assembly, and optical applica‑
tions. J Phys Chem B. 2005;109:13857–70.
 8. Huang X, Jain PK, El‑Sayed IH, El‑Sayed MA. Plasmonic photothermal 
therapy (PPTT) using gold nanoparticles. Lasers Med Sci. 2008;23:217–28.
 9. Lohse SE, Murphy CJ. The quest for shape control: a history of gold 
nanorod synthesis. Chem Mater. 2013;25:1250–61.
 10. Abad JM, Mertens SFL, Pita M, Fernández VM, Schiffrin DJ. Functionaliza‑
tion of thioctic acid‑capped gold nanoparticles for specific immobiliza‑
tion of histidine‑tagged proteins. J Am Chem Soc. 2005;127:5689–94.
 11. Vigderman L, Khanal BP, Zubarev ER. Functional gold nanorods: synthesis, 
self‑assembly, and sensing applications. Adv Mater. 2012;24:4811–41.
 12. Oh E, Delehanty JB, Sapsford KE, Susumu K, Goswami R, Blanco‑Canosa 
JB, Dawson PE, Granek J, Shoff M, Zhang Q, et al. Cellular uptake and fate 
of PEGylated gold nanoparticles is dependent on both cell‑penetration 
peptides and particle size. ACS Nano. 2011;5:6434–48.
 13. Luzio JP, Rous BA, Bright NA, Pryor PR, Mullock BM, Piper RC. Lysosome‑
endosome fusion and lysosome biogenesis. J Cell Sci. 2000;113(Pt 
9):1515–24.
 14. Jhaveri A, Torchilin V. Intracellular delivery of nanocarriers and targeting 
to subcellular organelles. Expert Opin Drug Deliv. 2016;13:49–70.
 15. Ahijado‑Guzmán R, Gómez‑Puertas P, Alvarez‑Puebla RA, Rivas G, Liz‑
Marzán LM. Surface‑enhanced Raman scattering‑based detection of the 
interactions between the essential cell division FtsZ protein and bacterial 
membrane elements. ACS Nano. 2012;6:7514–20.
 16. Ding L, Yao C, Yin X, Li C, Huang Y, Wu M, Wang B, Guo X, Wang Y. Size, 
shape, and protein corona determine cellular uptake and removal 
mechanisms of gold nanoparticles. Small. 2018;14:e1801451.
 17. Dramsi S, Cossart P. Listeriolysin O: a genuine cytolysin optimized for an 
intracellular parasite. J Cell Biol. 2002;156:943–6.
 18. Robbins JR, Barth AI, Marquis H, de Hostos EL, Nelson WJ, Theriot JA. 
Listeria monocytogenes exploits normal host cell processes to spread from 
cell to cell. J Cell Biol. 1999;146:1333–50.
 19. Hamon MA, Ribet D, Stavru F, Cossart P. Listeriolysin O: the Swiss army 
knife of Listeria. Trends Microbiol. 2012;20:360–8.
 20. Vázquez‑Boland JA, Kuhn M, Berche P, Chakraborty T, Domínguez‑Bernal 
G, Goebel W, González‑Zorn B, Wehland J, Kreft J. Listeria patho‑
genesis and molecular virulence determinants. Clin Microbiol Rev. 
2001;14:584–640.
 21. Tweten RK, Hotze EM, Wade KR. The unique molecular choreography of 
giant pore formation by the cholesterol‑dependent cytolysins of gram‑
positive bacteria. Annu Rev Microbiol. 2015;69:323–40.
 22. Bavdek A, Gekara NO, Priselac D, Aguirre IG, Darji A, Chakraborty T, Macek 
P, Lakey JH, Weiss S, Anderluh G. Sterol and pH interdependence in the 
binding, oligomerization, and pore formation of Listeriolysin O. Biochem‑
istry. 2007;46:4425–37.
 23. Gilbert RJ. Inactivation and activity of cholesterol‑dependent cytolysins: 
what structural studies tell us. Structure. 2005;13:1097–106.
 24. Schuerch DW, Wilson‑Kubalek EM, Tweten RK. Molecular basis of Listeri‑
olysin O pH dependence. Proc Natl Acad Sci USA. 2005;102:12537–42.
 25. Ruan Y, Rezelj S, Bedina Zavec A, Anderluh G, Scheuring S. Listeriolysin O 
membrane damaging activity involves arc formation and lineaction—
implication for listeria monocytogenes escape from phagocytic vacuole. 
PLoS Pathog. 2016;12:e1005597.
 26. Köster S, van Pee K, Hudel M, Leustik M, Rhinow D, Kuhlbrandt W, 
Chakraborty T, Özakan Y. Crystal structure of Listeriolysin O reveals 
molecular details of oligomerization and pore formation. Nat Commun. 
2014;5:3690–703.
 27. Podobnik M, Marchioretto M, Zanetti M, Bavdek A, Kisovec M, Cajnko MM, 
Lunelli L, Dalla Serra M, Anderluh G. Plasticity of Listeriolysin O pores and 
its regulation by pH and unique histidine. Sci Rep. 2015;5:9623.
 28. Decatur AL, Portnoy DA. A PEST‑like sequence in Listeriolysin O essential 
for Listeria monocytogenes pathogenicity. Science. 2000;290:992–5.
 29. Bavdek A, Kostanjsek R, Antonini V, Lakey JH, Serra MD, Gilbert RJC, 
Anderluh G. pH dependence of Listeriolysin O aggregation and pore‑
forming ability. FEBS J. 2012;279:126–41.
 30. Bhattacharjee S. DLS and zeta potential—What they are and what they 
are not? J Control Release. 2016;235:337–51.
 31. Back SA, Khan R, Gan X, Rosenberg PA, Volpe JJ. A new Alamar Blue viabil‑
ity assay to rapidly quantify oligodendrocyte death. J Neurosci Methods. 
1999;91:47–54.
 32. Bera D, Qian L, Tseng T, Holloway P. Quantum dots and their multimodal 
applications: a review. Materials. 2010;3:2260–345.
 33. Murray C, Kagan C, Bawendi M. Synthesis and characterization of mono‑
disperse nanocrystals and close‑packed nanocrystal assemblies. Annu 
Rev Mater Sci. 2000;30:545–610.
 34. Lee‑Montiel F, Li P, Imoukhuede P. Quantum dot multiplexing for the 
profiling of cellular receptors. Nanoscale. 2015;7:18504–14.
 35. Howarth M, Liu W, Puthenveetil S, Zheng Y, Marshall LF, Schmidt MM, 
Wittrup KD, Bawendi MG, Ting AY. Monovalent, reduced‑size quantum 
dots for imaging receptors on living cells. Nat Methods. 2008;5:397–9.
 36. Kim J, Park HY, Ryu J, Kwon DY, Grailhe R, Song R. Ni‑nitrilotriacetic 
acid‑modified quantum dots as a site‑specific labeling agent of 
histidine‑tagged proteins in live cells. Chem Commun. 2008. https ://doi.
org/10.1039/b7194 34j.
 37. Nguyen VH, Lee B‑J. Protein corona: a new approach for nanomedicine 
design. Int J Nanomed. 2017;12:3137–51.
 38. Ryman‑Rasmussen JP, Riviere JE, Monteiro‑Riviere NA. Surface coatings 
determine cytotoxicity and irritation potential of quantum dot nanoparti‑
cles in epidermal keratinocytes. J Invest Dermatol. 2007;127:143–53.
 39. Noh M, Kim T, Lee H, Kim C‑K, Joo S‑W, Lee K. Fluorescence quenching 
caused by aggregation of water‑soluble CdSe quantum dots. Colloids 
Surf A. 2010;359:39–44.
 40. Damalakiene L, Karabanovas V, Bagdonas S, Valius M, Rotomskis R. Intra‑
cellular distribution of nontargeted quantum dots after natural uptake 
and microinjection. Int J Nanomed. 2013;8:555–68.
Page 10 of 10Plaza‑GA et al. J Nanobiotechnol          (2019) 17:108 
•
 
fast, convenient online submission
 •
  
thorough peer review by experienced researchers in your field
• 
 
rapid publication on acceptance
• 
 
support for research data, including large and complex data types
•
  
gold Open Access which fosters wider collaboration and increased citations 
 
maximum visibility for your research: over 100M website views per year •
  At BMC, research is always in progress.
Learn more biomedcentral.com/submissions
Ready to submit your research ?  Choose BMC and benefit from: 
 41. Nishimura Y, Takeda K, Ezawa R, Ishii J, Ogino C, Kondo A. A display of 
pH‑sensitive fusogenic GALA peptide facilitates endosomal escape from 
a Bio‑nanocapsule via an endocytic uptake pathway. J Nanobiotechnol. 
2014;12:11.
 42. Allolio C, Magarkar A, Jurkiewicz P, Baxová K, Javanainen M, Mason PE, 
Šachl R, Cebecauer M, Hof M, Horinek D, et al. Arginine‑rich cell‑penetrat‑
ing peptides induce membrane multilamellarity and subsequently enter 
via formation of a fusion pore. Proc Natl Acad Sci USA. 2018;115:11923–8.
 43. Takechi‑Haraya Y, Saito H. Current understanding of physicochemical 
mechanisms for cell membrane penetration of arginine‑rich cell pen‑
etrating peptides: role of glycosaminoglycan interactions. Curr Protein 
Pept Sci. 2018;19:623–30.
 44. Fischer R, Kohler K, Fotin‑Mleczek M, Brock R. A stepwise dissection of 
the intracellular fate of cationic cell‑penetrating peptides. J Biol Chem. 
2004;279:12625–35.
 45. Kalafatovic D, Giralt E. Cell‑penetrating peptides: design strategies 
beyond primary structure and amphipathicity. Molecules. 1929;2017:22.
 46. El‑Sayed A, Khalil I, Kogure K, Futaki S, Harashima H. Octaarginine‑ and 
octalysine‑modified nanoparticles have different modes of endosomal 
escape. J Biol Chem. 2008;283:23450–61.
 47. Cryan S, Devocelle M, Moran P, Hickey A, Kelly J. Increased intracellular 
targeting to airway cells using octaarginine‑coated liposomes: in vitro 
assessment of their suitability for inhalation. Mol Pharm. 2006;3:104–12.
 48. Maxfield F, van Meer G. Cholesterol, the central lipid of mammalian cells. 
Curr Opin Cell Biol. 2010;22:422–9.
 49. Bornhorst J, Falke J. Purification of proteins using polyhistidine affinity 
tags. In: Applications of chimeric genes and hybrid proteins, Pt a. Vol. 326. 
pp. 245–54. 2000.
 50. Maxfield FR, Yamashiro DJ. Endosome acidification and the pathways of 
receptor‑mediated endocytosis. Adv Exp Med Biol. 1987;225:189–98.
 51. Wong B. Color blindness. Nat Methods. 2011;8:441.
 52. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of 
image analysis. Nat Methods. 2012;9:671–5.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in pub‑
lished maps and institutional affiliations.
